Randox Laboratories is an international clinical diagnostic solutions company with over 35 years' experience in the industry. Randox is a global market leader, providing revolutionary products for laboratories worldwide and is dedicated to improving health.
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. Spanning four key divisions - Life Sciences, Pharma Sciences, Research and Molecular - Randox Biosciences offers complete tailored solutions for clinical and research use.
From initial cultivation of raw materials for assay development, through to providing companion diagnostics, custom and molecular-based assays across a range of therapy areas, Randox Biosciences is a trusted partner supplying quality diagnostic solutions to the clinical, life science, pharmaceutical, research and biopharma industries. We specialise in supplying academic centres, genetics laboratories and the global biopharmaceutical industry with products tailored to their specific needs.
A key element to realising the potential for personalised medicine is in companion diagnostics (CDx) development. Randox Biosciences are committed to revolutionising healthcare by providing class-leading diagnostic, prognostic and predictive assays. Building on these unrivalled capabilities Randox is engaged in companion diagnostic programs with a number of global biopharma companies.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award-winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy-to-use format.
Randox Biosciences has been providing custom assay design, development and manufacturing services to the diagnostic, pharmaceutical, contract research and biotech industries. This also includes fully customised human and animal quality control sera and calibrators. Clients can select either individual or multiple analytes, we offer an impressive menu of over 380 clinical and research biomarkers.
Randox Biosciences is a world-leading primary manufacturer of high-quality monoclonal and polyclonal antibodies, antibody fragments and human recombinant proteins. In addition to our extensive off the shelf portfolio of over 1,000 products, Randox Biosciences provide a custom development service for antibodies and recombinant proteins including a specialised offering of antibody fragments.
Randox Biosciences range of molecular products offers diagnostic, prognostic and predictive solutions across a variety of disease areas including sexually transmitted infection, cardiovascular disease (CVD), familial hypercholesterolemia (FH), colorectal cancer and respiratory infection.
A wide range of assay formats are offered including SNP genotyping, pathogen detection, mutation detection and gene expression. These assays are optimised for use with the Randox Evidence Investigator semi-automated biochip analyser, giving consolidation, speed and ease-of-use.
Randox's core product lines of clinical chemistry reagents, quality controls and proficiency testing remain essential offerings for Randox Biosciences as these products are widely utilised in the world's leading academic research centres, pharmaceutical companies and contract research organisations.
To find out more about Randox Biosciences complete an enquiry form below.
As liquid biopsies begin to reveal their potential, the interest in antibody-based CDx is growing rapidly.
Randox Biosciences draws on three decades’ experience to create personalised, precise and cost-effective diagnostic techniques.
We are the ideal CDx partner; with over 220 FDA-cleared and 700 CE-marked assays, we offer the full package of diagnostic and CDx assay development, optimisation and regulatory approval.
